In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
In DepthDetails
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 8.90nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
In DepthDetails
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 9.5nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
In DepthDetails
In DepthDetails
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
In DepthDetails
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Rattus norvegicus (Rat))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Antagonist activity at rat TRPM8 by 45Ca2+ uptake assayMore data for this Ligand-Target Pair
In DepthDetails
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
In DepthDetails
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
In DepthDetails
In DepthDetails
In DepthDetails
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibition of TRPV1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 41nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 45nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
In DepthDetails
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 49nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
In DepthDetails
In DepthDetails
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
In DepthDetails
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 66nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Homo sapiens (Human))
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production pretreated 15 mins before LPS challenge measured ...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Homo sapiens (Human))
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
Affinity DataIC50: 74nMAssay Description:Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production pretreated 15 mins before LPS challenge measured ...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Homo sapiens (Human))
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production pretreated 15 mins before LPS challenge measured ...More data for this Ligand-Target Pair
In DepthDetails
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 90nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 94nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 97nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
In DepthDetails
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 107nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 111nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 8(Homo sapiens (Human))
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Glenmark Pharmaceuticals Ltd.
Curated by ChEMBL
Affinity DataIC50: 113nMAssay Description:Antagonist activity at human TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced 45Ca2+ uptake incubated for 10 mins prior to icili...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Homo sapiens (Human))
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
Sun Pharma Advanced Research Company Ltd
Curated by ChEMBL
Affinity DataIC50: 126nMAssay Description:Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production pretreated 15 mins before LPS challenge measured ...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)